0001209191-20-046870.txt : 20200814 0001209191-20-046870.hdr.sgml : 20200814 20200814210009 ACCESSION NUMBER: 0001209191-20-046870 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200813 FILED AS OF DATE: 20200814 DATE AS OF CHANGE: 20200814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOBULSKY SUSAN CENTRAL INDEX KEY: 0001820885 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 201107773 MAIL ADDRESS: STREET 1: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION STREET 2: 1551 EASTLAKE AVE E STE 200 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp CENTRAL INDEX KEY: 0001478320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270907024 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-659-0067 MAIL ADDRESS: STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: Adaptive TCR Corp DATE OF NAME CHANGE: 20091209 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-13 0 0001478320 Adaptive Biotechnologies Corp ADPT 0001820885 BOBULSKY SUSAN C/O ADAPTIVE BIOTECHNOLOGIES CORP. 1551 EASTLAKE AVE E STE 200 SEATTLE WA 98102 0 1 0 0 SVP, Diagnostics, clonoSEQ Stock Option (Right to Buy) 39.50 2020-08-13 4 A 0 20000 0.00 A 2030-08-13 Common Stock 20000 20000 D The options vest with respect to 1/4 of such shares on August 6, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. /s/ Susan Bobulsky by Eric Billings, Attorney-in-Fact 2020-08-14